Supreme Court Bars Pharma Industry From Excessive Medicine Pricing
The Supreme Court on Tuesday ruled that the pharmaceutical industry cannot be allowed to exploit free market principles to set maximum retail prices (MRP) of medicines at excessively high levels. The court highlighted cases where MRPs were over 1,000% higher than the prices at which medicines are sold to retailers, deeming such practices unacceptable.
Times of India·




